The proposed bankruptcy plan for Purdue Pharma, which would allocate billions of dollars to help ease the nation’s opioid crisis but shield the Sackler family from future lawsuits, has been placed on hold by the Supreme Court. Speaking to The Washington Post, Professor Ralph Brubaker, an expert in bankruptcy law, called the case one of the most important bankruptcy cases to ever come before the Court "from both a practical and a fundamental-justice perspective." Appellate courts have long been divided on whether those who haven’t declared bankruptcy, such as the individuals in the Sackler family, can be “released” from potential lawsuits through a bankruptcy reorganization, setting up a potentially precedent-setting opinion from the Supreme Court.
Read the full Washington Post article.